As a neurodegenerative disease, a reduced GMV is expected in PD patients, since the abnormal folding and deposition of alpha‐synuclein can lead to selective and progressive neuronal death through mechanisms such as mitochondrial damage, lysosomal dysfunction, and impaired calcium homeostasis [29]. This evidence concerns the gene SNCA and Parkinson disease.